Switch to:
More From Other Websites
The Zacks Analyst Blog Highlights: Google, Facebook, Apple, Microsoft and Regeneron Pharmaceuticals Sep 18 2014
Regeneron Gets Breakthrough Therapy Status for Eylea Sep 17 2014
Stocks Erase Modest Gains; Netflix Gaps Below 50-Day Line Sep 16 2014
EYLEA® (aflibercept) Injection Receives FDA Breakthrough Therapy Designation for Diabetic... Sep 16 2014
Biotech still place to be: Pro Sep 15 2014
[video] Biotech still place to be: Pro Sep 15 2014
US STOCKS-Biotech shares drop, Amarin plunges 20 pct Sep 12 2014
Stocks Show Modest Losses; Biotechs Pressured Again Sep 11 2014
Trading Guidelines for Amgen, Biogen Idec, Gilead, 3 Other Biotechs Sep 11 2014
Like Apple, these firms satisfy unmet need: Cramer Sep 10 2014
Stocks Hold Modest Gains; FleetCor Reverses Higher Sep 10 2014
Stocks Turn Higher After Soft Start; U.S. Silica Jumps Sep 10 2014
Bayer/Regeneron Looking for Eylea Label Expansion in Japan Sep 08 2014
Jim Cramer's fantasy stock portfolio Sep 05 2014
Jim Cramer's Top Stock Picks: MMM TSLA NFLX REGN DECK Sep 05 2014
[video] Regeneron Rises, Norwegian Cruises and CVS Health Quits the Habit Sep 04 2014
Jim Cramer's 'Mad Money' Recap: Stocks Are the Rational Choice Sep 04 2014
Cramer: Football lovers make good stock pickers? Sep 04 2014
[video] Cramer's WR stock pick: TSLA, NFLX, REGN Sep 04 2014
Amgen Seeks EU Approval for PCSK9 Inhibitor Evolocumab Sep 04 2014


Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

No comment yet


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK